Rhone-Poulenc's Giant Leap
Executive Summary
Rhone-Poulenc Rorer's new Gencell division is a radical departure for this conservative French company as well as for the industry. Instead of trying to fit one of series of biotech bets into a large internal research structure, it is creating an organization devoted to in-licensing a broad range of technologically compatible probrams centered around gene therapy and cell therapy.